Marinus Pharma (MRNS) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Marinus Pharma (MRNS) Reports In-Line Q4 EPS

Marinus Pharma (MRNS) Reports Q4, Provides Business Update

March 21, 2022 7:16 AM EDT

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and financial results for the fourth quarter and year ended December 31, 2021.

This year has already proven to be pivotal for Marinus following the FDAs approval of... More